You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

CLINICAL TRIALS PROFILE FOR LABETALOL HYDROCHLORIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Labetalol Hydrochloride

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000291 ↗	Effects of Labetalol on Human Cocaine Use - 8	Completed	University of Minnesota	Phase 2	1997-10-01	The purpose of this study is to determine the effect of labetalol treatment on the subjective and physiological effects of cocaine.
NCT00000291 ↗	Effects of Labetalol on Human Cocaine Use - 8	Completed	University of Minnesota - Clinical and Translational Science Institute	Phase 2	1997-10-01	The purpose of this study is to determine the effect of labetalol treatment on the subjective and physiological effects of cocaine.
NCT00000291 ↗	Effects of Labetalol on Human Cocaine Use - 8	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1997-10-01	The purpose of this study is to determine the effect of labetalol treatment on the subjective and physiological effects of cocaine.
NCT00000297 ↗	Effects of Labetalol on Nicotine Administration in Humans - 14	Completed	University of Minnesota	Phase 2	1998-10-01	The purpose of this study is to investigate the effects of labetalol in response to intravenous nicotine
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Labetalol Hydrochloride

Condition Name

Chart
Table

Condition Name for Labetalol Hydrochloride
Intervention	Trials
Hypertension in Pregnancy	7
Hypertension	6
Preeclampsia	6
Pre-Eclampsia	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Labetalol Hydrochloride
Intervention	Trials
Hypertension	23
Pre-Eclampsia	21
Hypertension, Pregnancy-Induced	16
Eclampsia	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Labetalol Hydrochloride

Trials by Country

Map
Table

Trials by Country for Labetalol Hydrochloride
Location	Trials
United States	40
Egypt	11
Canada	7
Saudi Arabia	2
India	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Labetalol Hydrochloride
Location	Trials
New York	11
Ohio	4
California	4
Texas	3
Tennessee	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Labetalol Hydrochloride

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Labetalol Hydrochloride
Clinical Trial Phase	Trials
Phase 4	24
Phase 3	6
Phase 2/Phase 3	2
[disabled in preview]	16
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Labetalol Hydrochloride
Clinical Trial Phase	Trials
Completed	28
Recruiting	13
Unknown status	8
[disabled in preview]	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Labetalol Hydrochloride

Sponsor Name

Chart
Table

Sponsor Name for Labetalol Hydrochloride
Sponsor	Trials
Weill Medical College of Cornell University	3
University of Alberta	3
Mansoura University	3
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Labetalol Hydrochloride
Sponsor	Trials
Other	83
NIH	4
U.S. Fed	4
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.